John F. Sheridan

2019

In 2019, John F. Sheridan earned a total compensation of $10.6M as President and Chief Executive Officer at Tandem Diabetes Care, a 445% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$738,225
Option Awards$9,319,134
Salary$500,000
Other$3,578
Total$10,560,937

Sheridan received $9.3M in option awards, accounting for 88% of the total pay in 2019.

Sheridan also received $738.2K in non-equity incentive plan, $500K in salary and $3.6K in other compensation.

Rankings

In 2019, John F. Sheridan's compensation ranked 676th out of 13,971 executives tracked by ExecPay. In other words, Sheridan earned more than 95.2% of executives.

ClassificationRankingPercentile
All
676
out of 13,971
95th
Division
Manufacturing
236
out of 5,701
96th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
28
out of 832
97th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
14
out of 535
97th
Industry
Surgical and Medical Instruments and Apparatus
7
out of 350
98th

Pay ratio

John F. Sheridan's Pay$10,560,937
Median Employee's Pay$105,295
Pay Ratio

100

to 1

In 2019, the annual total compensation of John F. Sheridan was $10,560,937.

The annual total compensation of the median employee at Tandem Diabetes Care was $105,295.

The ratio of John F. Sheridan's pay to the pay of median employee was therefore 100 to one.

Source: SEC filing on April 14, 2020.

Sheridan's colleagues

We found five more compensation records of executives who worked with John F. Sheridan at Tandem Diabetes Care in 2019.

2019

Kim Blickenstaff

Tandem Diabetes Care

Chief Executive Officer

2019

Brian Hansen

Tandem Diabetes Care

Executive Vice President, Chief Commercial Officer

2019

Leigh Vosseller

Tandem Diabetes Care

Chief Financial Officer

2019

David Berger

Tandem Diabetes Care

Secretary

2019

Susan Morrison

Tandem Diabetes Care

Chief Administrative Officer

News

In-depth

You may also like